drugset / Trial / NCT03269279
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso
NaSingle-groupOpen-labelTreatment
Summary
The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Burkina Faso.
Timeline
- Start
- 2017-05-20
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mifepristone | Small molecule | 200 mg | — |
| Subject | Misoprostol | Other / unclassified | 400 ug | — |
Indications
No indication recorded.